These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7911804)

  • 1. A 50 kDa protein present in conditioned medium of COLO-16 cells stimulates cell spreading and motility, and activates tyrosine phosphorylation of Neu/HER-2, in human SK-BR-3 mammary cancer cells.
    De Corte V; De Potter C; Vandenberghe D; Van Laerebeke N; Azam M; Roels H; Mareel M; Vandekerckhove J
    J Cell Sci; 1994 Mar; 107 ( Pt 3)():405-16. PubMed ID: 7911804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p185erbB2 protein is localized on cell organelles involved in cell motility.
    De Potter CR; Quatacker J
    Clin Exp Metastasis; 1993 Nov; 11(6):453-61. PubMed ID: 7900945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2.
    Lupu R; Colomer R; Zugmaier G; Sarup J; Shepard M; Slamon D; Lippman ME
    Science; 1990 Sep; 249(4976):1552-5. PubMed ID: 2218496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratinocyte induced chemotaxis in the pathogenesis of Paget's disease of the breast.
    de Potter CR; Eeckhout I; Schelfhout AM; Geerts ML; Roels HJ
    Histopathology; 1994 Apr; 24(4):349-56. PubMed ID: 7519165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Egf binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3.
    King CR; Borrello I; Bellot F; Comoglio P; Schlessinger J
    EMBO J; 1988 Jun; 7(6):1647-51. PubMed ID: 2901952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of Paget's disease: epidermal heregulin-alpha, motility factor, and the HER receptor family.
    Schelfhout VR; Coene ED; Delaey B; Thys S; Page DL; De Potter CR
    J Natl Cancer Inst; 2000 Apr; 92(8):622-8. PubMed ID: 10772679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heregulin stimulates mitogenesis and phosphatidylinositol 3-kinase in mouse fibroblasts transfected with erbB2/neu and erbB3.
    Carraway KL; Soltoff SP; Diamonti AJ; Cantley LC
    J Biol Chem; 1995 Mar; 270(13):7111-6. PubMed ID: 7535767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphiregulin induces tyrosine phosphorylation of the epidermal growth factor receptor and p185erbB2. Evidence that amphiregulin acts exclusively through the epidermal growth factor receptor at the surface of human epithelial cells.
    Johnson GR; Kannan B; Shoyab M; Stromberg K
    J Biol Chem; 1993 Feb; 268(4):2924-31. PubMed ID: 7679104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
    Ethier SP; Langton BC; Dilts CA
    Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunological approach reveals biological differences between the two NDF/heregulin receptors, ErbB-3 and ErbB-4.
    Chen X; Levkowitz G; Tzahar E; Karunagaran D; Lavi S; Ben-Baruch N; Leitner O; Ratzkin BJ; Bacus SS; Yarden Y
    J Biol Chem; 1996 Mar; 271(13):7620-9. PubMed ID: 8631797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-erbB-2 promoter-specific DNA-binding protein isolated from human breast cancer tissues displays mitogenic activity.
    Sarkar FH; Smith MR; Hoover T; Princler G; Crissman JD; Visscher DW; Longo DL; Kung HF; Raziuddin
    J Biol Chem; 1994 Apr; 269(16):12285-9. PubMed ID: 7909319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heregulin activation of extracellular acidification in mammary carcinoma cells is associated with expression of HER2 and HER3.
    Chan SD; Antoniucci DM; Fok KS; Alajoki ML; Harkins RN; Thompson SA; Wada HG
    J Biol Chem; 1995 Sep; 270(38):22608-13. PubMed ID: 7673253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells.
    Brockhoff G; Heiss P; Schlegel J; Hofstaedter F; Knuechel R
    Cytometry; 2001 Aug; 44(4):338-48. PubMed ID: 11500850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of c-erbB-2 gene product-related protein in culture medium conditioned by breast cancer cell line SK-BR-3.
    Alper O; Yamaguchi K; Hitomi J; Honda S; Matsushima T; Abe K
    Cell Growth Differ; 1990 Dec; 1(12):591-9. PubMed ID: 1981143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line.
    Ethier SP; Kokeny KE; Ridings JW; Dilts CA
    Cancer Res; 1996 Feb; 56(4):899-907. PubMed ID: 8631031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ErbB-beta-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-Neu transgenic carcinomas.
    Schroeder JA; Adriance MC; McConnell EJ; Thompson MC; Pockaj B; Gendler SJ
    J Biol Chem; 2002 Jun; 277(25):22692-8. PubMed ID: 11950845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-talk between phorbol ester-mediated signaling and tyrosine kinase proto-oncogenes. I. Activation of protein kinase C stimulates tyrosine phosphorylation and activation of ErbB2 and ErbB3.
    Emkey R; Kahn CR
    J Biol Chem; 1997 Dec; 272(49):31172-81. PubMed ID: 9388271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of heregulin, a specific activator of p185erbB2.
    Holmes WE; Sliwkowski MX; Akita RW; Henzel WJ; Lee J; Park JW; Yansura D; Abadi N; Raab H; Lewis GD
    Science; 1992 May; 256(5060):1205-10. PubMed ID: 1350381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells.
    Peles E; Bacus SS; Koski RA; Lu HS; Wen D; Ogden SG; Levy RB; Yarden Y
    Cell; 1992 Apr; 69(1):205-16. PubMed ID: 1348215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The extracellular domain of p185/neu is released from the surface of human breast carcinoma cells, SK-BR-3.
    Zabrecky JR; Lam T; McKenzie SJ; Carney W
    J Biol Chem; 1991 Jan; 266(3):1716-20. PubMed ID: 1671042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.